Hormone Replacement Therapy (HRT) – Global Strategic Business Report 2016-2022: Amid Controversies, Confusion and Competition, Demand for HRT Continues to Rise – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Hormone
Replacement Therapy (HRT) – Global Strategic Business Report”

report to their offering.

The report provides separate comprehensive analytics for the US, Canada,
Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates
and forecasts are provided for the period 2015 through 2022. Also, a
six-year historic analysis is provided for these markets. Market data
and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Hormone Replacement
Therapy (HRT) in US$ Thousand.

The report profiles 40 companies including many key and niche
players such as

  • Abbott Laboratories (US)
  • AbbVie, Inc. (US)
  • Allergan plc (Ireland)
  • Bayer Pharma AG (Germany)
  • Hisamitsu Pharmaceutical Co., Inc. (Japan)
  • Noven Pharmaceuticals, Inc. (US)
  • Novartis AG (Switzerland)
  • Novo Nordisk A/S (Denmark)
  • Orion Pharma AB (Finland)
  • Pfizer, Inc. (US)
  • Rottapharm Madaus (Italy)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • TherapeuticsMD, Inc. (US)

Key Topics Covered:

1. Outlook

2. Industry Overview

3. Market Trends & Issues

4. Competitive Landscape

5. Therapy Profile – A Review Of Select Recent Studies Conducted

6. Product Overview

7. Product Introductions/Approvals

8. Recent Industry Activity

9. Focus On Select Global Players

10. Global Market Perspective

Total Companies Profiled: 40 (including Divisions/Subsidiaries 47)

  • The United States (22)
  • Canada (3)
  • Japan (3)
  • Europe (12)
  • – Germany (1)
  • – The United Kingdom (5)
  • – Rest of Europe (6)
  • Asia-Pacific (Excluding Japan) (6)
  • Middle East (1)

For more information visit http://www.researchandmarkets.com/research/4nqktk/hormone

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals,
Women’s
Health